KIORA PHARMACEUTICALS INC·4

Oct 25, 5:32 PM ET

Tosca Melissa 4

4 · KIORA PHARMACEUTICALS INC · Filed Oct 25, 2022

Insider Transaction Report

Form 4
Period: 2022-10-21
Transactions
  • Award

    Common Stock

    2022-10-21+2,5002,500 total
  • Award

    Stock Option (right to buy)

    2022-10-21+5,0005,000 total
    Exercise: $6.78Exp: 2032-10-21Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the reporting person's continuous service through each such vesting date.
  • [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 13, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.

Documents

1 file
  • 4
    tm2228925-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT